About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Anxiety Clinical Trials in Philadelphia | 37 Studies

Clinical Trials AnxietyPhiladelphia

Anxiety Clinical Trials in Philadelphia

Find 37 clinical trials for anxiety near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Anxiety trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 37 trials

CompletedP3b Short-term Study of CTN in Patients With ADHD and Comorbid AnxietyPrimary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid…NCT06973577·Dothan, Alabama and 46 others

Anxiety Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingTriage Survey for Psychiatry Research EligibilityTRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.NCT05800925·Boston, Massachusetts and 5 others

CompletedAdaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)Anxiety is very common in autistic youth. Recently, an intervention has been created by the investigators to target these symptoms in autistic youth in a community setting.NCT06046170·Baltimore, Maryland and 2 others

CompletedChamomile Therapy for Generalized AnxietyThis study will determine the effectiveness of chamomile extract for treating generalized anxiety disorder.NCT00645983·Philadelphia, Pennsylvania

TerminatedA 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)This study will assess the long-term safety and tolerability of 350 to 600 mg/day of PD 0332334 administered in split dose (twice daily) in subjects with Generalized Anxiety…NCT00735267·Birmingham, Alabama and 92 others

CompletedA 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder…NCT00236015·Mesa, Arizona and 53 others

CompletedCombined Treatment for Generalized Anxiety Disorder (GAD)The purpose of this study is to conduct a preliminary evaluation of the efficacy of combined medication and psychotherapy for generalized anxiety disorder (GAD).NCT00620776·Philadelphia, Pennsylvania

CompletedEffectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XRThis study will assess the effectiveness of venlafaxine XR, randomized to either venlafaxine XR or placebo in preventing the relapse of generalized anxiety disorder after 6 months…NCT00183274·Philadelphia, Pennsylvania

CompletedProof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325The purpose of this research study is to determine whether AstraZeneca's drug AZD7325 is safe and effective in the treatment of generalized anxiety disorder.NCT00807937·Mesa, Arizona and 50 others

CompletedA Problem Solving Intervention for Hospice CaregiversHospice care is conceptualized as quality compassionate care for people facing a life-limiting illness, with services that cover clinical care, pain management, and emotional and…NCT03712410·Philadelphia, Pennsylvania

CompletedBlack Cohosh as Alternative Therapy for Treating Menopause-Related AnxietyThis study will determine the effectiveness of the herb black cohosh for treating menopause-related anxiety symptoms in women.NCT00120458·Philadelphia, Pennsylvania

CompletedSafety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderThe purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder.NCT00329446·Birmingham, Alabama and 62 others

CompletedA 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder…NCT00236067·Birmingham, Alabama and 20 others

CompletedGeneralized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD SubjectsTo determine the safety and efficacy of SEP-225441 (eszopiclone) in subjects with generalized anxiety disorder (GAD).NCT00616655·Birmingham, Alabama and 56 others

CompletedRandomized Trial of Adult Participants With Generalized Anxiety DisorderThe purpose of this study is to compare the efficacy of troriluzole versus placebo in participants with generalized anxiety disorder.NCT03829241·Little Rock, Arkansas and 52 others

Active not recruitingA Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - VoyageNCT06741228·Gilbert, Arizona and 33 others

CompletedSafety and Efficacy of Eszopiclone in Patients With Generalized Anxiety DisorderTo determine the safety and efficacy of eszopiclone as adjunctive therapy in the treatment of insomnia in patients with insomnia related to Generalized Anxiety Disorder.NCT00235508·Birmingham, Alabama and 63 others

CompletedDigital Data in Mental Health TherapyThe Use of Patient Electronic Communication in Psychiatric Evaluation and Treatment intends to better understand how digital data, social media, and electronic communication can…NCT04011540·Philadelphia, Pennsylvania

CompletedA Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)This is a randomized, double-blind, placebo controlled, multi-center outpatient study, in adults with GAD.NCT00248183·Mesa, Arizona and 19 others

CompletedStudy of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderThe purpose of this study is to evaluate the safety and efficacy of 2.5 mg and 10 mg vortioxetine, once daily (QD), in adults with generalized anxiety disorder.NCT00731120·Birmingham, Alabama and 39 others

Page 1 of 2Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia